EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseLeitlinieOpen Access · CC BY-NC 4.0

Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines

Asmamaw Demis Bizuneh, Anju E Joham iD, Helena Teede iD, Aya Mousa iD, Arul Earnest, James M Hawley, Laura Smith, Ricardo Azziz, Wiebke Arlt, Chau Thien Tay iD

Human Reproduction Update · 01.01.2025 · 31 (1) · 48-63

DOI: 10.1093/humupd/dmae028 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Human Reproduction Update, online erschienen am 20.09.2024. Verfasst von Asmamaw Demis Bizuneh und 9 weiteren Autor:innen. Beteiligte Einrichtung: Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Androgens, Hyperandrogenism. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: CRE in Polycystic Ovary Syndrome, European Society of Human Reproduction and Embryology, Monash International Tuition Scholarship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Biochemical hyperandrogenism is a hallmark and diagnostic feature of polycystic ovary syndrome (PCOS). However, the most accurate androgen measurement for assessing biochemical hyperandrogenism in PCOS diagnosis remains uncertain. OBJECTIVE AND RATIONALE This systematic review aimed to assess different androgen measures [including total testosterone (TT), calculated free testosterone (cFT), free androgen index (FAI), androstenedione (A4), dehydroepiandrosterone sulfate (DHEAS), and dihydrotestosterone (DHT)] for accuracy in diagnosing biochemical hyperandrogenism in women with PCOS, to inform the 2023 International PCOS Evidence-based Guidelines. SEARCH METHODS To update evidence from the 2018 International PCOS Guidelines, a systematic search from 3 July 2017 to 23 June 2023 was conducted across Medline (Ovid), CINAHL, all EBM, EMBASE, and PsycInfo for articles evaluating androgens in the diagnosis of biochemical hyperandrogenism. The revised Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) was used to assess the risk of bias and applicability. A diagnostic test accuracy meta-analysis was performed using STATA 18 software. Summary sensitivity and specificity were calculated with 95% CIs using the bivariate model, while the hierarchical summary receiver operating characteristics (ROC) model was used to produce a summary ROC curve. OUTCOMES Of 23 studies reviewed, 18 were included in the meta-analysis, with data from 2857 participants (1650 with PCOS and 1207 controls). For diagnosing biochemical hyperandrogenism in PCOS, the pooled sensitivity, specificity, and AUC with 95% CI were for TT: 0.74 (0.63–0.82), 0.86 (0.77–0.91), and 0.87 (0.84–0.90); cFT: 0.89 (0.69–0.96), 0.83 (0.79–0.86), and 0.85 (0.81–0.88); FAI: 0.78 (0.70–0.83), 0.85 (0.76–0.90), and 0.87 (0.84–0.90); A4: 0.75 (0.60–0.86), 0.71 (0.51–0.85), and 0.80 (0.76–0.83); and DHEAS: 0.75 (0.61–0.85), 0.67 (0.48–0.81), and 0.77 (0.73–0.81), respectively. In subgroup analyses, liquid chromatography with tandem mass spectrometry (LC-MS/MS) had superior sensitivity for measuring cFT, FAI, A4, and DHEAS, and superior specificity for measuring TT, cFT, and FAI, compared to the direct immunoassay method. WIDER IMPLICATIONS Our results directly informed the 2023 International PCOS Guideline recommendations to use TT and FT as the first-line laboratory tests to assess biochemical hyperandrogenism in the diagnosis of PCOS. cFT should be assessed by equilibrium dialysis or ammonium sulfate precipitation, or calculated using FAI. If TT or cFT are not elevated, A4 and DHEAS could also be considered, noting their poorer specificity. Laboratories should utilize LC-MS/MS for androgen measurement given its high accuracy. Future studies should focus on establishing optimal normative cut-off values in large, unselected, and ethnically diverse cohorts of women. REGISTRATION NUMBER The review protocol was prepublished in the 2023 PCOS Guideline Technical Report (https://www.monash.edu/__data/assets/pdf_file/0010/3379591/TechnicalReport-2023.pdf).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeAndrogensHyperandrogenismHumansFemaleTestosteroneSensitivity and SpecificityDehydroepiandrosterone SulfateAndrostenedionePractice Guidelines as TopicEvidence-Based Medicine

Stichwörter der Autor:innen

PCOSandrogendiagnostic accuracyhyperandrogenemiahyperandrogenismsensitivityspecificitytestosterone

Substanzen

AndrogensTestosteroneDehydroepiandrosterone SulfateAndrostenedione

Autor:innen und Institutionen

  • Monash Centre for Health Research and Implementation, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, VIC, Australia.
  • Department of Endocrinology and Diabetes, Monash Health, Clayton, Melbourne, VIC, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • Department of Clinical Biochemistry, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • Medical Research Council, Laboratory of Medical Sciences, London, UK.
  • School of Medical, Indigenous and Health Sciences, Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, NSW, Australia.

ORCID-Profile: Anju E Joham, Helena Teede, Aya Mousa, Chau Thien Tay

Förderung

  • CRE in Polycystic Ovary Syndrome
  • European Society of Human Reproduction and Embryology
  • Monash International Tuition Scholarship
  • Centre for Research Excellence for Women's Health in Reproductive Life
  • International Evidence-based Guideline in PCOS
  • NHMRC
  • Endocrine Society
  • European Society of Endocrinology

Zitieren

APA

Bizuneh, A. D., Joham, A. E., Teede, H., Mousa, A., Earnest, A., Hawley, J. M., Smith, L., Azziz, R., Arlt, W., & Tay, C. T. (2025). Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Human Reproduction Update, 31(1), 48-63. https://doi.org/10.1093/humupd/dmae028

Vancouver

Bizuneh AD, Joham AE, Teede H, Mousa A, Earnest A, Hawley JM, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Human Reproduction Update. 2025;31(1):48-63. doi:10.1093/humupd/dmae028

BibTeX
@article{Bizuneh2025,
  author = {Bizuneh, Asmamaw Demis and Joham, Anju E and Teede, Helena and Mousa, Aya and Earnest, Arul and Hawley, James M and Smith, Laura and Azziz, Ricardo and Arlt, Wiebke and Tay, Chau Thien},
  title = {Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines},
  journal = {Human Reproduction Update},
  year = {2025},
  volume = {31},
  number = {1},
  pages = {48--63},
  doi = {10.1093/humupd/dmae028}
}
Kostenlos starten →